Who invested in bluebird bio

6 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$151Mraised across 6 rounds since 2004, from 6 sources

$12MVenture$35MSeries B$4.2MGrant$30MVenture$60MSeries D$9.3MVenture

Latest round: Venture, $9.3MOct 2012
Biggest round: $60MSeries D · Jul 2012
Investors: 12

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2006200820102012

$12MVenture$35MSeries B$4.2MGrant$30MVenture$60MSeries D$9.3MVenture

First round: Venture, $12M
Biggest round: $60M
Usual gap between rounds: 12 months

The rounds

Oct 2012
Venture$9.3M1 new
- California Institute For Regenerative Medicine
Reported by in.finance.yahoo.comSEC filing: $60M sold, first sale Jul 2012
Jul 2012
Series D$60M3 new4 returning
Reported by in.finance.yahoo.comSEC filing: $60M sold, first sale Jul 2012
Apr 2011
Venture$30M1 new4 returning
Reported by live-pr.comSEC filing: $38M sold, first sale Mar 2010
Mar 2011
Grant$4.2M
No investor was named in the report.
From a historical funding recordSEC filing: $38M sold, first sale Mar 2010
Mar 2010
Series B$35M4 new1 returning
Reported by fiercebiotech.com
Oct 2004
Venture$12M3 new
From a historical funding record

Founders and team

From the SEC filings it signed: 3 on the team.

Chip BairdExecutive Officeri
Jason ColeExecutive Officeri
Nick S. LeschlyExecutive Officer, Directori

On the board, as filediDaniel S. LynchDenice R. TorresJohn S. AgwunobiMark R. VachonRamy S. IbrahimWendy S. DixonWilliam R. Sellers

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2004Series B2010Grant2011Venture2011Series D2012Venture2012

Forbion Capital Partners

Third Rock Ventures

TVM Capital

Easton Capital

ARCH Venture Partners

RA Capital Management

ABN AMRO FundTechno Venture Management

Sanofi-Genzyme BioVentures

Ramius

The exit

ExitListingPriceWhen

IPONASDAQ:BLUE$101MJun 2013

From historical deal records. Wrong? Tell us.

Everyone who backed them

Forbion Capital PartnersPrivate equity3rounds

Third Rock VenturesVC firm3rounds

TVM CapitalPrivate equity3rounds

Easton CapitalVC firm3rounds

ARCH Venture PartnersVC firm2rounds

RA Capital ManagementPrivate equity1round

ABN AMRO FundCorporate VC1round

Techno Venture ManagementVC firm1round

Sanofi-Genzyme BioVenturesCorporate VC1round

RamiusHedge fund1round

Deerfield PartnersVC firm1round

California Institute For Regenerative MedicineVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about bluebird bio

Who invested in bluebird bio?

bluebird bio's investors include Forbion Capital Partners, Third Rock Ventures, TVM Capital, Easton Capital and ARCH Venture Partners, and 7 more on record.